Recent Quarter Total Invested
$303.55 M
Recent Quarter Institutional Ownership Percentage
80.8%
Total Invested of Last Quarter
$335.68 M
Ownership Percentage of Last Quarter
111.47%
Esperion Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
WASATCH ADVISORS LP | 08/14/2024 | 16.86 M | $37.44 M | 84.71% | 9.96% |
BLACKROCK INC. | 08/13/2024 | 13.98 M | $31.04 M | 392.59% | 8.26% |
VANGUARD GROUP INC | 08/13/2024 | 10.82 M | $24.01 M | 22.55% | 6.39% |
BELLEVUE GROUP AG | 08/14/2024 | 9.94 M | $22.08 M | 0.00% | 5.88% |
MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 6.51 M | $14.46 M | 14.65% | 3.85% |
GREAT POINT PARTNERS LLC | 08/14/2024 | 5.79 M | $12.86 M | -27.61% | 3.42% |
TWO SEAS CAPITAL LP | 08/14/2024 | 5.74 M | $12.73 M | 37.69% | 3.39% |
WOODLINE PARTNERS LP | 08/14/2024 | 5.05 M | $11.21 M | -36.26% | 2.98% |
MARSHALL WACE, LLP | 08/14/2024 | 4.30 M | $9.55 M | 94.21% | 2.54% |
GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 4.16 M | $9.24 M | 137.26% | 2.46% |
TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 4.07 M | $9.05 M | 2.50% | 2.41% |
TWO SIGMA ADVISERS, LP | 08/14/2024 | 3.87 M | $8.60 M | 8.53% | 2.29% |
MEDITOR GROUP LTD | 07/22/2024 | 3.79 M | $8.42 M | 0.00% | 2.24% |
STATE STREET CORP | 08/14/2024 | 3.75 M | $8.34 M | 581.09% | 2.22% |
MORGAN STANLEY | 10/17/2024 | 3.33 M | $7.39 M | 102.69% | 1.97% |
WHITEFORT CAPITAL MANAGEMENT, LP | 08/14/2024 | 2.30 M | $5.10 M | 100.00% | 1.36% |
NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 2.27 M | $5.05 M | 100.00% | 1.34% |
JPMORGAN CHASE & CO | 08/12/2024 | 2.05 M | $4.55 M | -1.71% | 1.21% |
RHENMAN & PARTNERS ASSET MANAGEMENT AB | 08/13/2024 | 1.98 M | $4.38 M | 100.00% | 1.17% |
CENTERBOOK PARTNERS LP | 08/12/2024 | 1.57 M | $3.48 M | 100.00% | 0.93% |
DEUTSCHE BANK AG\ | 08/14/2024 | 1.53 M | $3.40 M | 100.00% | 0.91% |
CITADEL ADVISORS LLC | 08/14/2024 | 1.52 M | $3.38 M | -54.74% | 0.90% |
RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 1.42 M | $3.16 M | -32.82% | 0.84% |
PLATINUM INVESTMENT MANAGEMENT LTD | 08/13/2024 | 1.20 M | $2.66 M | -25.10% | 0.71% |
BANK OF AMERICA CORP /DE/ | 08/14/2024 | 1.16 M | $2.58 M | -74.40% | 0.69% |
PARKMAN HEALTHCARE PARTNERS LLC | 08/14/2024 | 1.14 M | $2.54 M | 0.15% | 0.68% |
QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 1.10 M | $2.45 M | -31.40% | 0.65% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 934,800 | $2.08 M | 54.85% | 0.55% |
GOLDMAN SACHS GROUP INC | 08/13/2024 | 916,011 | $2.03 M | -72.77% | 0.54% |
SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2024 | 847,727 | $1.88 M | -10.53% | 0.50% |
GSA CAPITAL PARTNERS LLP | 08/15/2024 | 813,399 | $1.81 M | 81.11% | 0.48% |
DIAMETRIC CAPITAL, LP | 08/13/2024 | 743,842 | $1.65 M | 868.75% | 0.44% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 08/14/2024 | 595,016 | $1.32 M | -15.49% | 0.35% |
BANK OF NEW YORK MELLON CORP | 07/25/2024 | 572,323 | $1.27 M | 3,278.33% | 0.34% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 554,914 | $1.23 M | 856.90% | 0.33% |
WALLEYE TRADING LLC | 08/14/2024 | 525,200 | $1.17 M | -8.66% | 0.31% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 518,958 | $1.15 M | -74.63% | 0.31% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 505,900 | $1.12 M | 23.66% | 0.30% |
BANK OF MONTREAL /CAN/ | 08/14/2024 | 429,852 | $958,570 | 744.50% | 0.25% |
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 08/09/2024 | 415,900 | $923,298 | 100.00% | 0.25% |
NORTHERN TRUST CORP | 08/14/2024 | 405,038 | $899,184 | 31.22% | 0.24% |
CITADEL ADVISORS LLC | 08/14/2024 | 391,000 | $868,020 | 64.29% | 0.23% |
D. E. SHAW & CO., INC. | 08/14/2024 | 382,488 | $849,123 | -92.56% | 0.23% |
CAPTION MANAGEMENT, LLC | 08/14/2024 | 368,800 | $818,736 | 63.91% | 0.22% |
XTX TOPCO LTD | 08/12/2024 | 364,681 | $809,592 | 751.62% | 0.22% |
WELLINGTON MANAGEMENT GROUP LLP | 08/14/2024 | 361,424 | $802,361 | 0.17% | 0.21% |
GRAHAM CAPITAL MANAGEMENT, L.P. | 08/14/2024 | 341,890 | $758,996 | 100.00% | 0.20% |
INSPIRE INVESTING, LLC | 08/12/2024 | 341,223 | $757,515 | 100.00% | 0.20% |
MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 300,000 | $666,000 | 100.00% | 0.18% |
PINNACLE ASSOCIATES LTD | 07/30/2024 | 281,299 | $624,484 | -1.37% | 0.17% |
Esperion Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of ESPR shares?
During the previous two years, 251 institutional investors and hedge funds held shares of Esperion Therapeutics, Inc.. The most heavily invested institutionals were:
WASATCH ADVISORS LP: 23.35 M
BlackRock Funding, Inc. /DE: 14.26 M
Bellevue Group AG: 9.94 M
Two Seas Capital LP: 6.58 M
GEODE CAPITAL MANAGEMENT, LLC: 4.33 M
STATE STREET CORP: 3.85 M
-
What percentage of Esperion Therapeutics, Inc. stock is owned by institutional investors?
80.80% of Esperion Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at ESPR ?
Institutional investors have bought a total of 132.60 M shares in the last 24 months. This purchase volume represents approximately $335.48 M in transactions.